NASDAQ IMMY

Welcome to the Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) investor resource site.  Imprimis was founded on a simple commitment: To make innovative medications available at affordable prices -- and to build a highly profitable company at the same time. Meeting this commitment allows our team to make a positive impact in the lives of the customers we serve. Imprimis is a fast-growing company -- but also a highly-focused company -- building a growing foothold in the U.S. ophthalmology market with a portfolio of innovative pharmaceutical solutions. Read More >

Stock Quote
Latest News Releases
Upcoming Events
Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today

 

Stay Informed

Interested in receiving investor news and updates?

Click Here


Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.